CARA.OL
Price:
$21.1
Market Cap:
$1.53B
Carasent ASA provides cloud-based medical record services to the health care industry in the Nordic region. The company develops Webdoc, a cloud based EMR-system; and Vårdrummet, a digital platform for interactive health care that enables healthcare providers to communicate with their patients through digital services, such as video, chat, and other channels. It also provides Ad Voca, Ad Opus, and Ad Curis. The company was formerly known as Apptix ASA and changed its name to Carasent ASA in May 2019. Carasent ASA was founded in 1997 and is based in Oslo, Norway.
Industry
Medical - Healthcare Information Services
IPO Date
2000-06-30
Stock Exchange
OSL
Ticker
CARA.OL
According to Carasent ASA’s latest financial reports and current stock price. The company's current ROE is -0.84%. This represents a change of 291.33% compared to the average of -0.21% of the last 4 quarters.
The mean historical ROE of Carasent ASA over the last ten years is 22.55%. The current -0.84% ROE has changed -103.72% with respect to the historical average. Over the past ten years (40 quarters), CARA.OL's ROE was at its highest in in the December 2016 quarter at 207.88%. The ROE was at its lowest in in the December 2014 quarter at -98.15%.
Average
22.55%
Median
1.26%
Minimum
-96.13%
Maximum
220.16%
Discovering the peaks and valleys of Carasent ASA ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 161.23%
Maximum Annual ROE = 220.16%
Minimum Annual Increase = -20210.84%
Minimum Annual ROE = -96.13%
Year | ROE | Change |
---|---|---|
2023 | -4.86% | -291.30% |
2022 | 2.54% | -20210.84% |
2021 | -0.01% | -99.87% |
2020 | -9.51% | -368.17% |
2019 | 3.55% | -146.08% |
2018 | -7.70% | -123.22% |
2017 | 33.15% | -84.94% |
2016 | 220.16% | 161.23% |
2015 | 84.28% | -187.67% |
2014 | -96.13% | -2747.16% |
The current ROE of Carasent ASA (CARA.OL) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-0.78%
5-year avg
-1.66%
10-year avg
22.55%
Carasent ASA’s ROE is less than ArcticZymes Technologies ASA (0.40%), greater than Smart Eye AB (publ) (-14.53%), greater than BerGenBio ASA (-102.29%), less than Kitron ASA (16.40%), less than Nekkar ASA (13.07%),
Company | ROE | Market cap |
---|---|---|
0.40% | $827.36M | |
-14.53% | $2.85B | |
-102.29% | $48.78M | |
16.40% | $12.09B | |
13.07% | $1.05B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Carasent ASA using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Carasent ASA or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Carasent ASA's ROE?
How is the ROE calculated for Carasent ASA (CARA.OL)?
What is the highest ROE for Carasent ASA (CARA.OL)?
What is the 3-year average ROE for Carasent ASA (CARA.OL)?
What is the 5-year average ROE for Carasent ASA (CARA.OL)?
How does the current ROE for Carasent ASA (CARA.OL) compare to its historical average?